Data

TROG 15.01 SPARK Stereotactic Prostate Adaptive Radiotherapy utilising Kilovoltage intrafraction monitoring (SPARK)

Health Data Australia Contributor Records
Trans Tasman Radiation Oncology Group (TROG Cancer Research) ; Keall, Paul ; Martin, Jarad ; Trans Tasman Radiation Oncology Group (TROG) ; The University Of Sydney
Viewed: [[ro.stat.viewed]] Cited: [[ro.stat.cited]] Accessed: [[ro.stat.accessed]]
ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Adc&rfr_id=info%3Asid%2FANDS&rft_id=info:doi10.58118/P5KS-ZH06&rft.title=TROG 15.01 SPARK Stereotactic Prostate Adaptive Radiotherapy utilising Kilovoltage intrafraction monitoring (SPARK)&rft.identifier=http://doi.org/10.58118/P5KS-ZH06&rft.publisher=Trans Tasman Radiation Oncology Group (TROG Cancer Research)&rft.description=Dataset Contains: Changes in dosimetric coverage of the prostate and normal healthy structures with KIM, Patient treatment outcomes determined by assessing:, Biochemical-clinical failure (BCF), Acute and late toxicity grade 3 or higher (using CTCAE version 4), Patient-reported outcomes one and two years after treatment, patient and radiation therapist perception of KIM, and give guidelines on how the system could be improved, improvement in the overall beam-target accuracy., QOL data: (EPIC)-26 (Baseline, 2 weeks post RT, 6 weeks post RT, 12 months post RT, 36 months post RT), Imaging Data: Cone Beam Computed Tomorgraphy (CBCT) scan, Approx Time of data collection: 2016-2020 Radiotherapy Quality Assurance, 48 participants RT Plan, RT delivery and Imaging documentation, plus KIM data and RapidPlan models/RTQA feedback (DICOM format), 5 participants Benchmarking datasets&rft.creator=Trans Tasman Radiation Oncology Group (TROG Cancer Research) &rft.creator=Keall, Paul &rft.creator=Martin, Jarad &rft.creator=Trans Tasman Radiation Oncology Group (TROG) &rft.creator=The University Of Sydney &rft.date=2023&rft.relation=https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=ACTRN12615000335594&rft_subject=Radiation Therapy&rft.type=dataset&rft.language=English Access the data
Cite Saved to MyRDA Save to MyRDA

Full description

Dataset Contains: Changes in dosimetric coverage of the prostate and normal healthy structures with KIM, Patient treatment outcomes determined by assessing:, Biochemical-clinical failure (BCF), Acute and late toxicity grade 3 or higher (using CTCAE version 4), Patient-reported outcomes one and two years after treatment, patient and radiation therapist perception of KIM, and give guidelines on how the system could be improved, improvement in the overall beam-target accuracy., QOL data: (EPIC)-26 (Baseline, 2 weeks post RT, 6 weeks post RT, 12 months post RT, 36 months post RT), Imaging Data: Cone Beam Computed Tomorgraphy (CBCT) scan, Approx Time of data collection: 2016-2020 Radiotherapy Quality Assurance, 48 participants RT Plan, RT delivery and Imaging documentation, plus KIM data and RapidPlan models/RTQA feedback (DICOM format), 5 participants Benchmarking datasets

Notes

HeSANDA 1.0.0

Issued: 2023

This dataset is part of a larger collection

Click to explore relationships graph
Help

Related Publications

Related Organisations

Related People

Subjects
Radiation Therapy |

User Contributed Tags    

Login to tag this record with meaningful keywords to make it easier to discover

Other Information
Trans Tasman Radiation Oncology Group (TROG Cancer Research)

ROR : https://ror.org/02cyrpr98

Trans Tasman Radiation Oncology Group (TROG)

ROR : https://ror.org/02cyrpr98

Prostate Cancer Foundation of Australia

ROR : https://ror.org/02kna3n95

Cancer Australia

ROR : https://ror.org/00510tw04

Identifiers
Similar data you may be interested in: